Role of Lymphocyte Subsets and Laboratory Measurements in COVID-19 Disease
NCT04779359 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1
Last updated 2021-03-03
Summary
To investigate the predictive role of lymphocyte subsets and other laboratory measurements in adult patients with COVID-19.This was a single center, retrospective study that involved adult patients with confirmed diagnosis of COVID-19. Electronic medical records were reviewed. Data including age, sex, symptom from onset to hospital admission and laboratory findings at admission of hospitalized patients with confirmed COVID-19 were extracted and analyzed retrospectively.This study indicates that the levels of lymphocyte subsets (CD4+, and CD8+) are associated with disease progression and severity, along with prognosis in patients with COVID-19.
Conditions
- COVID-19 Disease
Sponsors & Collaborators
-
Shanghai Public Health Clinical Center
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-04-30
- Primary Completion
- 2021-08-31
- Completion
- 2021-12-31
More Related Trials
-
Dynamics of Markers of Infection and Inflammation in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients
NCT04887623 ·Status: RECRUITING
-
Immune Changes in Severe COVID-19 Pulmonary Infections
NCT04386395 ·Status: COMPLETED
-
Understanding COVID-19
NCT04329546 ·Status: COMPLETED
-
Development and Qualification of Methods for Analyzing the Mucosal Immune Response to COVID-19
NCT06142279 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Lymphocyte to Procalcitonin Ratio in Covid-19 Patients
NCT06620159 ·Status: ACTIVE_NOT_RECRUITING
-
Understanding Immunology and Patient Outcomes of COVID-19 in Hospitalized Patients
NCT04892797 ·Status: TERMINATED
-
Study on Immune Status of Patients With COVID-19
NCT05682573 ·Status: UNKNOWN
-
Comparison of the Immune Response to Natural COVID-19 Infection and Vaccination
NCT04706390 ·Status: RECRUITING
-
The Role of Natural Killer, Complement and T-lymphocytes in COVID-19 Disease, a Prospective Monocentric Study
NCT05258643 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Inflammatory Cytokines During COVID-19
NCT04824495 ·Status: UNKNOWN
-
Association of Neutrophil- Lymphocyte Count Ratio and Microbial Infection in Hospitalized Patients
NCT06759662 ·Status: NOT_YET_RECRUITING
-
Multiparametric Assessment of Peripheral Blood and Tissue Myeloid Cells. Phenotype for Precision Medicine in Patients With SARS-Cov-2 Infection
NCT05767853 ·Status: UNKNOWN
-
HLA-G Immuno-Inhibitor Checkpoint Study in Patients With COVID-19 Infection: Molecular and Cellular Assessment
NCT04613297 ·Status: COMPLETED ·Phase: NA
-
Monocytes and NK Cells Activity in Covid-19 Patients
NCT04375176 ·Status: UNKNOWN
-
COVID-19 Contact Study by Antigen Detection Test
NCT04745533 ·Status: WITHDRAWN
-
Study of Leukocyte Immunophenotype and the Lipid Transport System as Predictive Biomarkers of Severe Bacterial Infections
NCT04178915 ·Status: ENROLLING_BY_INVITATION
-
Dynamic Evaluation of COVID-19 Diagnostic Tests
NCT04337996 ·Status: COMPLETED ·Phase: NA
-
Immunological Characteristics of COVID-19 Patients
NCT04679428 ·Status: UNKNOWN
-
Study of Kinetics and Efficacy of the Immune Response Against COVID-19 Among Hospital Staff
NCT04408001 ·Status: COMPLETED
-
Clinical and Immunological Characterisation of COVID-19 in Children, Adolescents and Adults
NCT04341168 ·Status: UNKNOWN
-
Clinical, Virological, Serological and Immunological Characteristics During and Following COVID-19 Hospitalization
NCT05274373 ·Status: UNKNOWN
-
Characterisation of the Immune Response to SARS-CoV-2 / COVID-19
NCT04729452 ·Status: COMPLETED
-
InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort
NCT04407689 ·Status: TERMINATED ·Phase: PHASE2
-
Expression of Toll-like Receptors 3 , 7 and 9 in Peripheral Blood Mononuclear Cells of COVID-19 Patients
NCT05089110 ·Status: UNKNOWN
-
COVID-19 Vaccine Reactogenicity and Immunogenicity
NCT05258708 ·Status: UNKNOWN